0161 504 8999
info@nasgp.org.uk
Clinical updates and guidelines for GP locums
This episode provides an overview of acute leukaemia: its diagnosis and management, with a focus on presentations in primary care.
NASGP members can attend a talk on best practice on prostate cancer in our September webinar, ‘GP update: Prostate cancer’, scheduled for Thursday 4 September, 1-2pm.
A new update from Nice on bone cancer risk.
Newly-updated for 2025.
Guidelines were released in April and June; guidance on relugolix CT was released with much fanfare, so you’ll probably have heard about it in the news.
The NASGP’s July talk will be chaired by Prof Steven Knapper, honorary consultant haematologist at Cardiff and Vale University Health Board.
The Intrauterine ball (IUB) is otherwise known as Ballerine and is a copper IUD.
Clinical psychologists Dr Jess Gough and Dr Alesia Moulton-Perkins provide a comprehensive overview of ADHD and autism diagnosis, treatment, and patient care for GPs.
This is a new guideline from SIGN on preventing Type 2 Diabetes. It was published in March 2025.
NASGP members are invited to a new talk, 'Better outcomes for patients with ADHD and autism', by Dr Alesia Moulton-Perkins and Dr Jessie Gough.
This is guidance from NICE on tirzepatide (Mounjaro) in overweight and obesity was first published in December 2024.
NICE has approved the use of a new immunotherapy for treating house dust mite-related allergic rhinitis.
Rachel Ainley, the head of research at Crohn’s and Colitis UK, joins lead nurse Pearl Avery for another free webinar.
Consultant from Guy's and St Thomas' Hospital London to present on fast and slow symptoms of vision loss to NASGP members in April.
When you discover Patients’ Unmet Needs you have found your first PUN, leading you on to then construct your DEN.
Experienced nurse Claire Coughlan, clinical lead for Bowel Cancer UK, presents the NASGP’s second webinar given at 1pm on Thursday 6 February.
There's a recommendation for every GP to skim these new guidelines, Dr Louise Hudman writes.
A guideline from the British Society of Haematology published in April 2024.
Experienced nurse Claire Coughlan, clinical lead for Bowel Cancer UK, will present the NASGP’s second webinar of the year at 1pm on Thursday 6 February.
Dr Heidi Mounsey, medicolegal consultant at Medical Protection, explains how inquests work and why it is important that GP locums are aware of the process.
Like Mirabegron, Vibegron is also a beta-3 adrenergic receptor agonist.
GP speaker Dr Varun Anand will present ‘Physical activity for long-term conditions’ for NASGP’s last webinar of 2024.
It advises that CYP2C19 genotype testing can be carried out on certain people to see if they will respond to clopidogrel.
© 2025 NASGP
Amelia House, Crescent Road, Worthing, BN11 1QR 0161 504 8999 info@nasgp.org.uk
Design by James Walker | Built by UnitedUs